Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGINTERVENTIONAL

Care Bundle Containing Chlorhexidine Dressing on Port Catheter and Central Venous Catheters

Care Bundle Containing Chlorhexidine Dressing on Port Catheter and Central Venous Catheter-Related Bloodstream Infections in Pediatric Cancer Patients

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

In order to provide treatment in pediatric hematology-oncology patients, in some cases a central venous catheter is required in children. The most important situation to pay attention to when using a central venous catheter is "Central line-associated bloodstream infections". These infections are infections that develop after admission to the hospital and are not in the incubation period at the time of admission, or although they usually develop in the hospital 48-72 hours after hospitalization, they can sometimes appear after discharge. Central line-associated bloodstream infections significantly increase morbidity and mortality. In this context, the effect of using a care bundle containing chlorhexidine dressing on port catheter and central venous catheter-related bloodstream infections in pediatric cancer patients was examined.

Who May Be Eligible (Plain English)

Who May Qualify: - The child is receiving inpatient treatment at the Hematology and Oncology unit and hematopoietic stem cell transplantation unit - The child has a diagnosis of hematological or oncological cancer - The child's age range is between 1 and 17 - Having a port catheter inserted and no early complications have occurred - The child agrees to participate in the study voluntarily - The parent agrees to participate in the study voluntarily - Obtaining the consent form from the child and parent - He has been in the hospital for more than 48 hours Who Should NOT Join This Trial: - Have a systemic infection. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * The child is receiving inpatient treatment at the Hematology and Oncology unit and hematopoietic stem cell transplantation unit * The child has a diagnosis of hematological or oncological cancer * The child's age range is between 1 and 17 * Having a port catheter inserted and no early complications have occurred * The child agrees to participate in the study voluntarily * The parent agrees to participate in the study voluntarily * Obtaining the consent form from the child and parent * He has been in the hospital for more than 48 hours Exclusion Criteria: * Have a systemic infection.

Treatments Being Tested

DEVICE

Chlorhexidine Dressing

Transparent catheter cover with Chlorhexidine (3M™ CHG Tegaderm™)

Locations (1)

Gülçin Özalp Gerçeker
Izmir, Turkey (Türkiye)